CLEARSIDE BIOMEDICAL INC (CLSDQ)
Institutional ownership reported to the SEC as of Q2 2026, across 29 quarters.
1
Reporting holders
$3.3K
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| DRW Securities, LLC | $3.3K | 27,136 | 0.00% | 3q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1 | $3.3K | 27,136 | 0 | 0 | 0 | 0.0% |
| Q1 2026 | 1 | $7.9K | 27,136 | 0 | 0 | 0 | 0.0% |
| Q4 2025 | 1 | $19.1K | 27,136 | 1 | 0 | 0 | 0.0% |
| Q3 2025 | 23 | $1.7M | 424,797 | 23 | 0 | 0 | 0.0% |
| Q1 2025 | 2 | $35.7K | 0 | 0 | 0 | 0 | 100.0% |
| Q4 2024 | 2 | $133.5K | 0 | 0 | 0 | 0 | 100.0% |
| Q3 2024 | 2 | $106.1K | 0 | 1 | 0 | 0 | 100.0% |
| Q2 2024 | 1 | $56.9K | 0 | 0 | 0 | 0 | 100.0% |
| Q1 2024 | 1 | $68.8K | 0 | 0 | 0 | 0 | 100.0% |
| Q4 2023 | 2 | $32.2K | 0 | 0 | 0 | 0 | 100.0% |
| Q3 2023 | 2 | $28.4K | 0 | 0 | 0 | 0 | 100.0% |
| Q2 2023 | 2 | $36.6K | 0 | 0 | 0 | 0 | 100.0% |
| Q1 2023 | 2 | $36.8K | 0 | 0 | 0 | 0 | 100.0% |
| Q4 2022 | 2 | $108.5K | 0 | 0 | 0 | 0 | 100.0% |
| Q3 2022 | 2 | $183.0K | 0 | 0 | 0 | 0 | 100.0% |
| Q2 2022 | 2 | $281.0K | 0 | 0 | 0 | 0 | 100.0% |
| Q1 2022 | 2 | $479.0K | 0 | 0 | 0 | 0 | 100.0% |
| Q4 2021 | 2 | $443.0K | 0 | 0 | 0 | 0 | 100.0% |
| Q3 2021 | 3 | $2.3M | 0 | 1 | 0 | 0 | 100.0% |
| Q2 2021 | 2 | $1.6M | 0 | 0 | 0 | 0 | 100.0% |
| Q1 2021 | 2 | $273.0K | 0 | 3 | 0 | 0 | 100.0% |
| Q4 2020 | 1 | $4.0K | 0 | 0 | 0 | 0 | 100.0% |
| Q3 2020 | 1 | $40.0K | 0 | 0 | 0 | 0 | 100.0% |
| Q2 2020 | 2 | $1.2M | 0 | 0 | 0 | 0 | 100.0% |
| Q1 2020 | 2 | $1.2M | 0 | 0 | 0 | 0 | 100.0% |
| Q4 2019 | 2 | $1.6M | 0 | 4 | 0 | 0 | 100.0% |
| Q2 2019 | 2 | $148.0K | 0 | 0 | 0 | 0 | 100.0% |
| Q1 2019 | 2 | $224.0K | 0 | 1 | 0 | 0 | 100.0% |
| Q4 2018 | 2 | $20.0K | 0 | 0 | 0 | 0 | 100.0% |